UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Monarch Alternative Capital LP 535 MADISON AVENUE NEW YORK, NY 10022 |
 |  X |  | See Remarks |
MDRA GP LP C/O MONARCH ALTERNATIVE CAPITAL LP 535 MADISON AVENUE NEW YORK, NY 10022 |
 |  X |  | See Remarks |
Monarch GP LLC C/O MONARCH ALTERNATIVE CAPITAL LP 535 MADISON AVENUE NEW YORK, NY 10022 |
 |  X |  | See Remarks |
MONARCH ALTERNATIVE CAPITAL LP, By: /s/ Michael A. Weinstock, Chief Executive Officer | 10/06/2016 | |
**Signature of Reporting Person | Date |
No securities are beneficially owned | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
 Remarks: Exhibit List: Exhibit 99.1 - Joint Filers' Information and Signatures This Form 3 is being filed on behalf of Monarch Alternative Capital LP, a Delaware limited partnership ("MAC"), MDRA GP LP, a Delaware limited partnership ("MDRA GP"), and Monarch GP LLC, a Delaware limited liability company ("Monarch GP"). MAC serves as the investment advisor to certain investment funds, MDRA GP is the general partner of MAC, and Monarch GP is the general partner of MDRA GP. Solely for purposes of Section 16 of the Exchange Act, each of MAC, and by virtue of their control of MAC, MDRA GP and Monarch GP, are directors-by-deputization by virtue of MAC's designation of Patrick Bartels, a managing principal of MAC, to ARCH's board of directors. |